These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37276726)

  • 1. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
    Mu F; Wang M; Huang J; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():29-35. PubMed ID: 37276726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux Results in Similar Pregnancy Outcomes with Lower Adverse Reaction Rates Compared to Low Molecular Weight Heparin in Chinese Recurrent Miscarriage Women.
    Liu C; Ma C; Hao Y
    Tohoku J Exp Med; 2024 Mar; 262(2):125-131. PubMed ID: 38057118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials.
    Wang G; Zhang R; Li C; Chen A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7601-7608. PubMed ID: 34311655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
    Yan X; Wang D; Yan P; Li H
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
    Kahale LA; Matar CF; Hakoum MB; Tsolakian IG; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006649. PubMed ID: 34878173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal medicines for unexplained recurrent miscarriage.
    Li L; Dou L; Leung PC; Chung TK; Wang CC
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
    Potdar N; Gelbaya TA; Konje JC; Nardo LG
    Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
    Middleton P; Shepherd E; Gomersall JC
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis.
    Jiang F; Hu X; Jiang K; Pi H; He Q; Chen X
    Taiwan J Obstet Gynecol; 2021 Jan; 60(1):1-8. PubMed ID: 33494980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin in thrombophilic women receiving in vitro fertilization/intracytoplasmic sperm injection: A meta-analysis.
    Chen J; Bie J; Jiang F; Wu Y; Pan Z; Meng Y; Song J; Liu Y
    Acta Obstet Gynecol Scand; 2023 Nov; 102(11):1431-1439. PubMed ID: 37475190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.